Video: Every Case Tells a Story| Webinar: ACR/CHEST ILD Guidelines in Practice

An official publication of the ACR and the ARP serving rheumatologists and rheumatology professionals

Alendronate May Provide Cardiovascular Benefits; Plus FDA Approves Subcutaneous Tocilizumab

  |  

No new safety signals were identified.

Michele B. Kaufman, PharmD, BCGP, is a freelance medical writer based in New York City and a pharmacist at New York Presbyterian Lower Manhattan Hospital.

ADVERTISEMENT
SCROLL TO CONTINUE

References

  1. Staff. Osteoporosis drug may benefit heart health. FirstWord Pharma. 2018 May 13.
  2. Genentech Inc. News release: FDA approves subcutaneous formulation of Actemra for use in active polyarticular juvenile idiopathic arthritis (PJIA), a rare form of juvenile arthritis. 2018 May 14.

Related Articles